Chai, Shoujie http://orcid.org/0000-0002-5621-8725
Ruiz-Velasco, Carmen
Naghdloo, Amin
Pore, Milind http://orcid.org/0000-0001-6513-653X
Singh, Mohan
Matsumoto, Nicholas
Kolatkar, Anand http://orcid.org/0000-0002-8621-1073
Xu, Liya http://orcid.org/0000-0002-5501-2039
Shishido, Stephanie
Aparicio, Ana
Zurita, Amado J.
Hicks, James http://orcid.org/0000-0001-5353-4338
Kuhn, Peter http://orcid.org/0000-0003-2629-4505
Funding for this research was provided by:
Prostate Cancer Foundation (17CHAL01, 17CHAL01, 17CHAL01)
Breast Cancer Research Foundation (BCRF-20-089, BCRF-20-089)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5P30CA014089-40)
Vicky Joseph Research Fund; Vassiliadis Research Fund; Susan Pekarovics Research Fund
David and Janet Polak Foundation Fellowship in Convergent Science; Kalayil & Leela Chacko M.D. Fellowship
Article History
Received: 3 January 2022
Accepted: 19 May 2022
First Online: 21 June 2022
Competing interests
: P.K., J.H., and A.K. hold ownership interest (including patents) in, and P.K. and J.H. hold advisory roles a consultant to Epic Sciences. S.C., C.R-V., N.M., A.K., J.H. and P.K. are royalty recipients on related technology licensed to Epic Sciences for development. No potential competing interests were disclosed by the other authors.